Management of Atrial Fibrillation With Flecainide : the AFFLEC Study

Multicentre Non Interventional Study in the Management of Atrial Fibrillation With Flecainide

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02190175

Enrollment

100

Registered

2014-07-15

Start date

2014-06-30

Completion date

2015-12-31

Last updated

2018-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

This is a multicentre non interventional observational study with the objective to follow up patients with atrial fibrillation who based on current indications are treated with per os flecainide , for cardiac pulse maintenance.

Detailed description

the study objectives are * record safety and efficiency of flecainide as antiarrythmic treatment in atrial fibrillation * study of flecainide in ST interval

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* patients with history of atrial fibrillation * patients able to give informed consent

Exclusion criteria

* patients with coronary disease or other cardiopathy with left heart champer affected

Design outcomes

Primary

Measure	Time frame
ST interval and repolarization measures of myocardia in patients under treatment of flecainide	6months

Countries

Greece

Outcome results